Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 94 of the 98 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We aimed to estimate pooled percentages of patients with adrenal insufficiency after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we aimed to stratify the results by route of administration, disease, treatment dose, and duration. METHODS: We searched seven electronic databases (PubMed, MEDLINE, EMBASE, COCHRANE, CENTRAL, Web of Science, and CINAHL/Academic Search Premier) in February 2014 to identify potentially relevant studies. Original articles testing adult corticosteroid users for adrenal insufficiency were eligible. RESULTS: We included 74 articles with a total of 3753 participants. Stratified by administration form, percentages of patients with adrenal insufficiency ranged from 4.2% for nasal administration (95% confidence interval [CI], 0.5-28.9) to 52.2% for intra-articular administration (95% CI, 40.5-63.6). Stratified by disease, percentages ranged from 6.8% for asthma with inhalation corticosteroids only (95% CI, 3.8-12.0) to 60.0% for hematological malignancies (95% CI, 38.0-78.6). The risk also varied according to dose from 2.4% (95% CI, 0.6-9.3) (low dose) to 21.5% (95% CI, 12.0-35.5) (high dose), and according to treatment duration from 1.4% (95% CI, 0.3-7.4) (<28 d) to 27.4% (95% CI, 17.7-39.8) (>1 year) in asthma patients. CONCLUSIONS: 1) Adrenal insufficiency after discontinuation of glucocorticoid occurs frequently; 2) there is no administration form, dosing, treatment duration, or underlying disease for which adrenal insufficiency can be excluded with certainty, although higher dose and longer use give the highest risk; 3) the threshold to test corticosteroid users for adrenal insufficiency should be low in clinical practice, especially for those patients with nonspecific symptoms after cessation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk also varied when stratified for the underlying disease and increased with higher dose (low dose 2.4% (95% CI 0.6-9.3) to high dose 21.5% (95% CI 12.0-35.5)) and longer treatment duration (1.4% (95% CI 0.3-7.4) (<28 days) to 27.4% (95% CI 17.7-39.8) (>1 year)) in patients with asthma.”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“A meta-analysis of the risk of developing biochemical glucocorticoid-induced adrenal insufficiency stratified by glucocorticoid route of administration showed pooled percentages of 4.2% (95% CI 0.5-28.9) for nasal administration, 48.7% (95% CI 36.9-60.6) for oral use, and 52.2% (95% CI 40.5-63.6) for intra-articular administration (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Of these 521 patients, 98 patients had biochemical evidence of adrenal insufficiency. Ten of them (10%) reported symptoms. However, 88 (90%) did not report any symptoms”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“In the above-mentioned meta-analysis, ten of the 74 included studies also assessed symptoms of adrenal insufficiency (although not systematically scored) in a total of 521 patients (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Broersen et al performed a meta-analysis on eleven out of seventeen studies re-testing patients for biochemical adrenal insufficiency for which results could be categorized in short-term (defined as less than 4 weeks) high-dose glucocorticoid therapy re-testing after 4 weeks (six studies), and long-term (>1 year) medium-dose glucocorticoid therapy re-testing after 6 months (five studies) (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
Distinguishing Case Series From Cohort Studies
Dekkers, O. M., Egger, M., Altman, D. G., & Vandenbroucke, J. P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-1-201201030-00006 · Cited by 308
Self-citationSuppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X. H., & Briner, V. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06290-x · Cited by 290
Greenberg, G., Feagan, B., Martin, F., Sutherland, L., Thomson, A., Williams, C., Nilsson, L., & Persson, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536887 · Cited by 288
Research works printed but not linked: 1
- Ruiz Munoz, 1988, Adrenocortical function and steroid doses in renal transplant patients, Dial Transplant, 17, 184
Cited by
Items 201–300 of 457
Abrahão, R., Brunson, A. M., Ruddy, K. J., Li, Q., Li, J., Ryder, M. M., Chubak, J., Nichols, H. B., Sauder, C. A. M., Gray, M. F., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02594-x · Cited by 8
Vulto, A., Minović, I., de Vries, L. V., Timmermans, A. C., van Faassen, M. H. J. R., Neto, A. W. G., Touw, D. J., de Jong, M. F. C., van Beek, A. P., Dullaart, R. P. F., et al. (2020) · Clinical Transplantation · doi:10.1111/ctr.13824 · Cited by 9
Adrenal insufficiency: identification and management—summary of new NICE guidance
Ftouh, S., Zucker, M., Tran, A., Tollerfield, S., Williams, K., & Simpson, H. (2025) · BMJ · doi:10.1136/bmj.r330 · Cited by 7
SARS-CoV-2 Affects Thyroid and Adrenal Glands: An 18F-FDG PET/CT Study
Lauri, C., Campagna, G., Glaudemans, A. W. J. M., Slart, R. H. J. A., van Leer, B., Pillay, J., Colandrea, M., Grana, C. M., Stigliano, A., & Signore, A. (2023) · Biomedicines · doi:10.3390/biomedicines11112899 · Cited by 7
Einarsdottir, M. J., Kirui, B. K., Li, H., Olsson, D. S., Johannsson, G., Nyberg, F., & Ragnarsson, Ó. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080640 · Cited by 8
Impact of Surreptitious Glucocorticoids in Over-the-Counter Arthritis Supplements
Wei, K. S., Torre, M. O. D. L., Flores, A., Chiu, C. E., Hurtado, C., & Angell, T. E. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae227 · Cited by 7
Cucuzza, L. S., BIOLATTI, B., Scaglione, F. E., & Cannizzo, F. T. (2017) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2017.08.001 · Cited by 7
Komminoth, M., Donath, M. Y., Hepprich, M., Schüetz, P., Blum, C. A., Müeller, B., Reny, J., Gosselin, P., Bréville, G., Brändle, M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281585 · Cited by 11
Rare Adverse Events Associated with Corticosteroid Injections: A Case Series and Literature Review
Smuin, D. M., Seidenberg, P. H., Sirlin, E. A., Phillips, S. F., & Silvis, M. L. (2016) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000000259 · Cited by 7
Risk assessment, diagnosis, and treatment of cancer treatment-related adrenal insufficiency
Hayes, A. G., Rushworth, R. L., & Torpy, D. J. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2023009 · Cited by 7
Zhou, F., Shi, Y. X., Zhao, G., Aufderklamm, S., Murray, K. S., & Jin, B. (2022) · Translational Andrology and Urology · doi:10.21037/tau-22-501 · Cited by 6
Galetaki, D. M., Szymczuk, V. L., Shi, M., & Merchant, N. (2024) · eNeurologicalSci · doi:10.1016/j.ensci.2024.100513 · Cited by 6
“Patients with DMD are inevitably at high risk of secondary adrenal insufficiency due to chronic high dose glucocorticoid use and suppression of the hypothalamic-pituitary-adrenal axis (HPA) [39].”
BackgroundJones, A. W., McDonald, V. M., McLoughlin, R. F., Vella, T., Flynn, A. W. P., Blakey, J., Wolfenden, L., Hew, M. J., Upham, J. W., Thomas, D., et al. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s487743 · Cited by 6
“12,13 Adrenal insufficiency can present with non-specific signs and symptoms such as, fatigue, weight loss and gastrointestinal upset or life-threatening emergencies such as acute adrenal crisis.”
Hjortdahl, F., Soendergaard, M. B., Hansen, S., Bjerrum, A., von Bülow, A., Hilberg, O., Bonnesen, B., Johnsen, C. R., Johansson, S. L., Rasmussen, L. M., et al. (2025) · Lung · doi:10.1007/s00408-025-00796-5 · Cited by 6
Ayudhaya, A. C. N., Morrison, S. R., Kaliaperumal, C., & Gallo, P. (2022) · Child s Nervous System · doi:10.1007/s00381-022-05569-6 · Cited by 6
Awareness of Side Effects of Corticosteroids among Users and Nonusers in Saudi Arabia
Al-jabr, K. H., Alhumaidan, L. S., Alghamdi, A. A., Almutairi, M. S. L., Alsubaihi, A. A., Alrasheedi, S., Alkhdairi, A., Alzweihary, A. M., Alrasheedi, M. S., AL-Rasheedi, K. A., et al. (2024) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_925_23 · Cited by 9
Iatrogenic Cushing’S Syndrome as a Consequence of Nasal Use of Betamethasone Spray During Pregnancy
Scutelnicu, A. M., Panaitescu, A. M., Ciobanu, A.-M., Gică, N., Botezatu, R., Peltecu, G. C., & Gheorghiu, M. L. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.511 · Cited by 6
Wang, X., Luo, Y., & Feng, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.720154 · Cited by 6
Llahana, S., Mulligan, K., Hirani, S. P., Wilson, S., Baldeweg, S. E., Grossman, A. B., Norton, C. S., Sharman, P., McBride, P., & Newman, S. P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1207715 · Cited by 8
Outcome of a glucocorticoid discontinuation regimen in patients with inactive systemic sclerosis
Iudici, M., Vettori, S., Russo, B. F., Giacco, V., Capocotta, D., & Valentini, G. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3300-3 · Cited by 6
Pokrzywa, A., Ambroziak, U., Foroncewicz, B., Macech, M., Pączek, L., Florczak, M., Mucha, K., & Bednarczuk, T. (2019) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15091 · Cited by 8
Impact of COVID-19 on an Academic Pain Fellowship Program
Prem, A. M. (2020) · Pain Physician · doi:10.36076/ppj.2020/23/s433 · Cited by 6
Hintong, S., Phinyo, P., Chuamanochan, M., Phimphilai, M., & Manosroi, W. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s342841 · Cited by 9
Yoon, J. H., Ahn, S., Jung, S., Lee, J., Choi, W., Park, J. Y., Hong, A. R., Kim, H. K., & Kang, H. (2021) · BioMed Research International · doi:10.1155/2021/2330417 · Cited by 9
Kasahara, A., Kida, T., Hirano, A., Ōmura, S., Sofue, H., Sakashita, A., Sagawa, T., Asano, M., Fukui, M., Wada, M., et al. (2022) · Modern Rheumatology · doi:10.1093/mr/roab091 · Cited by 6
Tan, J. W., & Majumdar, S. K. (2022) · Case Reports in Endocrinology · doi:10.1155/2022/4798466 · Cited by 6
Lessons from iatrogenic Cushing syndrome in children
Messazos, B., & Zacharin, M. (2016) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.13273 · Cited by 8
Pelewicz, K., & Miśkiewicz, P. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02304-7 · Cited by 6
L’insuffisance surrénalienne chez l’adulte
Jublanc, C., & Bruckert, É. (2016) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2016.02.007 · Cited by 8
Prevention and Management of Adrenal Crisis in Children and Adults
Llahana, S., Zopf, K., Mitchelhill, I., & Grossman, A. B. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_62 · Cited by 7
Przybyszowski, M., Piliński, R., Śliwka, A., Polczyk, R., Nowobilski, R., Sładek, K., & Bochenek, G. (2020) · Journal of Asthma · doi:10.1080/02770903.2020.1841791 · Cited by 5
McDowell, P. J., Busby, J., & Heaney, L. G. (2023) · Current Treatment Options in Allergy · doi:10.1007/s40521-023-00330-z · Cited by 5
Lawrence, N., Arshad, M. F., Pofi, R., Ashby, S., Dawson, J., Tomlinson, J., Newell-Price, J. D. C., Ross, R. J. M., Elder, C. J., & Debono, M. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad127 · Cited by 5
Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy
Feldt‐Rasmussen, U. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae005 · Cited by 7
Glucocorticoid prescribing in neurology
Jones, A. P., Debono, M., Walsh, J., Smith, C., Hunt, L., & McKevitt, F. M. (2024) · Practical Neurology · doi:10.1136/pn-2023-003855 · Cited by 5
Braido, F., Vlachaki, I., Nikolaidis, G. F., Tzelis, D., Barouma, I., Piraino, A., Madoni, A., & Scichilone, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-88374-w · Cited by 7
Manosroi, W., Phimphilai, M., Khorana, J., Atthakomol, P., & Pipanmekaporn, T. (2020) · Medicina · doi:10.3390/medicina56010023 · Cited by 7
Guzmán, V., Kenny, R. A., & Feeney, J. C. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104701 · Cited by 6
Intra‐articular corticosteroid injections during the COVID‐19 lockdown period: A service evaluation
Newton, A. C., Jones, G. M., Jones, J. W. M., Norris, R., & Barabás, A. (2020) · Musculoskeletal Care · doi:10.1002/msc.1530 · Cited by 6
Egalini, F., Caprino, M. P., Gaggero, G., Cappiello, V., Giannelli, J., Giaccherino, R. R., Pagano, L., & Giordano, R. (2021) · Endocrines · doi:10.3390/endocrines2030018 · Cited by 5
Diagnosis and management of secondary adrenal crisis
Martel‐Duguech, L., Poirier, J., Bourdeau, I., & Lacroix, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09877-x · Cited by 8
Willms, A., Schumm‐Draeger, P., & Siegmund, T. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0070-0 · Cited by 7
Cucuzza, L. S., Pregel, P., BIOLATTI, B., & Cannizzo, F. T. (2020) · Research in Veterinary Science · doi:10.1016/j.rvsc.2020.09.018 · Cited by 5
Joseph, R. M., Ray, D. W., Keevil, B. G., van Staa, T. P., & Dixon, W. G. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000700 · Cited by 5
“Our findings are in agreement with a meta-analysis that demonstrated a trend of increasing AI prevalence from low to high GC dose.(14) However, our current study found no association with duration of exposure to GCs when only current GC users were considered.”
BackgroundResultInfluentialLee, H., & Yoon, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-78298-2 · Cited by 7
“We found that ICS use increased the risk of AI in patients with chronic airway disease, consistent with previous findings 12–14 .”
InfluentialCucuzza, L. S., Divari, S., BIOLATTI, B., & Cannizzo, F. T. (2020) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2020.106473 · Cited by 5
Subedi, P., Kim, M., Lee, J.-H., Park, J. K., & Oh, T. (2022) · Biophysical Chemistry · doi:10.1016/j.bpc.2022.106875 · Cited by 5
Varlamov, E. V., & Fleseriu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00019-6 · Cited by 6
Current Screening Strategies for the Diagnosis of Adrenal Insufficiency in Children
Bowden, S. A. (2023) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s334576 · Cited by 5
Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency
Dorin, R. I., Qiao, Z. G., Bouchonville, M. F., Qualls, C., Schrader, R. M., & Urban, F. K. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00198 · Cited by 5
Libianto, R., Yang, J., & Fuller, P. J. (2021) · Australian Journal of General Practice · doi:10.31128/ajgp-09-20-5619 · Cited by 4
Corticotrophins, Corticosteroids, and Prostaglandins
Brophy, A., & Ray, S. D. (2015) · Side effects of drugs annual · doi:10.1016/bs.seda.2015.05.004 · Cited by 4
Do glucocorticoids induce addiction in humans?
Giordano, R., Guaraldi, F., Mazzoli, M., & Ghigo, E. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0656-4 · Cited by 4
Diagnosis and Management of Adrenal Insufficiency in Children and Adults
Llahana, S., Mitchelhill, I., Yeoh, P., & Quinkler, M. O. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_37 · Cited by 8
Kline, G. A., Symonds, C. J., & Holmes, D. T. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.78162 · Cited by 4
Plasma pharmacometabolomics of inhaled corticosteroid–related adrenal suppression in asthma
Tran, D. T., Chen, Y., Ramirez, L. G., Lasky-Su, J. A., Wu, A. C., Tantisira, K. G., McGeachie, M. J., Weiss, S. T., & Dahlin, A. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.02.037 · Cited by 3
Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion
Law, C. C. Y., Sheskier, R., Viera, N., Delgado-Nieves, A., Seth, S., Hanžel, J., Ma, C., Colombel, J., Levine, A. C., Spencer, E. A., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf136 · Cited by 4
Lin, K. F., Stewart, C. R., Steig, P. E., Brennan, C., Gutin, P. H., & Selesnick, S. H. (2018) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/s-0038-1641752 · Cited by 3
Vicentini, J. R. T., Habibollahi, S., Staffa, S. J., Simeone, F. J., Kheterpal, A., Graeber, A., Bredella, M. A., & Chang, C. Y. (2022) · Radiology · doi:10.1148/radiol.220271 · Cited by 3
“In a metaanalysis by Broersen et al (14), adrenal insufficiency was seen in up to 52.”
Correa, N., & Orlando, R. A. (2023) · WikiJournal of Medicine · doi:10.15347/wjm/2023.002 · Cited by 3
Tsiakas, S., Angelousi, A. G., Benetou, V., Orfanos, P., Xagas, E., Boletis, J., & Marinaki, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226712 · Cited by 5
“%) for AI in KTRs, second only to patients with hematologic malignancies [10].”
InfluentialAdrenal insufficiency in severely wounded men with combat gunshot injury
Seliukova, N. Y., Misiura, K. V., Khoroshun, E. M., Макаров, В. В., Nehoduiko, V. V., Zalyubovska, O. I., & Szucsik, E. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.20.8.2024.1463 · Cited by 3
Expert consensus on oral corticosteroid use and tapering in severe asthma management
Kim, J., Kang, N., Kang, S., Sim, D. W., Park, S., Park, J., Lee, H. J., Jin, H. J., Song, W., Kim, S. R., et al. (2025) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2025.13.1.12 · Cited by 3
The role of the clinical laboratory in diagnosing hyponatremia disorders
Berend, K., & Heldeweg, M. L. A. (2025) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2025.2462814 · Cited by 6
“After clearance of osmoles, the remaining volume component is water "free" of solute [89].”
InfluentialTurmel-Roy, J., Bédard, M.-A., Millette, M., Simonyan, D., Proulx‐Gauthier, J., & Rousseau-Nepton, I. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0219 · Cited by 4
Adrenal insufficiency in hospitalized patients with multiple myeloma
Ahn, S., Kim, H. K., Kang, H., Kim, M., Song, G., Jung, S., Ahn, J., Yang, D., Kim, H., & Lee, J. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1834095 · Cited by 3
Sivapalan, P., Bikov, A., Ulrik, C. S., Lapperre, T. S., Mathioudakis, A. G., Lassen, M. C. H., Skaarup, K. G., Biering‐Sørensen, T., Vestbo, J., & Jensen, J. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122734 · Cited by 3
Witte, J. A., Braunstahl, G., Blox, W. J. B., Westeinde, S. C. V. ‘., Veen, J. C. C. M. I. ’., Kappen, J. H., & van Rossum, E. F. C. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01843-0 · Cited by 5
Acute Severe Hypovolemic Hyponatremia in a Patient on Intravenous Dexamethasone
Peer, S., Sharma, D., Prasad, C., & Karthik, K. (2022) · Cureus · doi:10.7759/cureus.23080 · Cited by 4
Shima, H., Miya, K., Okada, K., Doi, T., & Minakuchi, J. (2023) · Cureus · doi:10.7759/cureus.38234 · Cited by 3
Smith, C. B., Baker, D., Botchu, R., Cairns, M. C., Chester, R., Dean, B. J. F., Mast, R., & Lewis, J. S. (2023) · New Zealand Journal of Physiotherapy · doi:10.15619/nzjp.v51i3.363 · Cited by 4
Modelling Adverse Events in Patients Receiving Chronic Oral Corticosteroids in the UK
Gibson, D., Branscombe, N., Martin, N., Menzies-Gow, A. N., Jain, P., Padgett, K., & Yeates, F. (2024) · PharmacoEconomics - Open · doi:10.1007/s41669-024-00520-8 · Cited by 5
Is Adrenal Insufficiency a Rare Disease?
Dahlqvist, P. M., Isaksson, M., & Bensing, S. (2016) · Frontiers of hormone research · doi:10.1159/000443870 · Cited by 3
Menzella, F., Ghidoni, G., Fontana, M., Capobelli, S., Livrieri, F., Castagnetti, C., & Facciolongo, N. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.2004123 · Cited by 4
Li, S., Li, Z., Fan, L., Устиченко, В. Д., Pakhomov, O. V., & Deng, B. (2021) · Cryobiology · doi:10.1016/j.cryobiol.2021.07.011 · Cited by 3
Alam, M. M., Tariq, M., Bondugulapati, L. N. R., Pasha, M. A., Bashir, J., Hassan, U., & Awan, T. A. (2022) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.1055/s-0042-1750181 · Cited by 3
Lessons to learn from the 2024 NICE guideline on adrenal insufficiency
Dong, J., & Tomlinson, J. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00307-3 · Cited by 2
Symonds, C. J., Leung, A. A. C., & Kline, G. A. (2026) · Clinical Endocrinology · doi:10.1111/cen.70102 · Cited by 2
Li, L., Yue, R., Zeng, L., Wang, S., Zhuo, W., & Sun, Y. (2020) · Medicine · doi:10.1097/md.0000000000023011 · Cited by 3
“Long-term glucocorticoid therapy can increase blood glucose, blood pressure, blood lipid levels, body weight and cause disorders of bone metabolism, Cushingoid features and abdominal discomfort.([16,17]) Those adverse events lead to high treatment discontinuation rate, unsatisfying curative efficacy, and a high recurr…”
Treatments for poorly controlled asthma
O’Carroll, O., McCarthy, C., & Butler, M. W. (2021) · BMJ · doi:10.1136/bmj.n2355 · Cited by 2
Lethbridge, D., & O’Shea, S. (2022) · Musculoskeletal Care · doi:10.1002/msc.1707 · Cited by 2
Einarsdottir, M. J., Kristjansdottir, H. L., Bergthorsdottir, R., Johannsson, G., Trimpou, P., Lewerin, C., & Ragnarsson, Ó. (2023) · Acta Haematologica · doi:10.1159/000534317 · Cited by 2
Ge, Y., Liu, M., Deng, X., & Liao, L. (2023) · Molecules · doi:10.3390/molecules29010200 · Cited by 2
“Moreover, glucocorticoids could significantly inhibit the production of cortisol, aldosterone, and dehydroepiandrosterone (DHEA) by negative feedback of the hypothalamic-pituitary-adrenal (HPA) axis [11–13].”
BackgroundCanonica, G. W., Mazziotti, G., Repici, A., Povero, M., Castello, L., Pradelli, L., Dobreva, M., Fanelli, F., Saab, J. P., & Savarino, E. V. (2024) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2024.100383 · Cited by 2
Wood, C. L., Lane, L. C., Barlow, H., Drake, A. J., Kanthagnany, S.-K., Pearce, M. S., Sachdev, P., Blair, J., & Cheetham, T. D. (2024) · Archives of Disease in Childhood · doi:10.1136/archdischild-2024-327510 · Cited by 3
Fifteen-minute consultation: An approach to the child receiving glucocorticoids
Kanthagnany, S.-K., Lane, L. C., Wood, C. L., Sachdev, P., Drake, A. J., & Cheetham, T. D. (2020) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2019-317812 · Cited by 2
Noé, S., Jaeger, H., & Heldwein, S. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418768689 · Cited by 2
Corticotrophins, Corticosteroids, and Prostaglandins
Brophy, A., & Ray, S. D. (2016) · Side effects of drugs annual · doi:10.1016/bs.seda.2016.08.020 · Cited by 2
Possible adrenal insufficiency among fatigue patients in a psychosomatic medical clinic
Matsubayashi, S., Nakatake, N., & Hara, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0096 · Cited by 6
CME: Nebennierenrindeninsuffizienz
Fischli, S. (2018) · Praxis · doi:10.1024/1661-8157/a002982 · Cited by 2
Management of endocrine conditions at the end of life
de Bray, A., Tomas, J., Gittoes, N. J. L., & Hassan-Smith, Z. K. (2020) · British Journal of Hospital Medicine · doi:10.12968/hmed.2020.0096 · Cited by 2
Foppiani, L. (2021) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.1177/11795514211026615 · Cited by 2
Irish Thoracic Society Annual Scientific Meeting 2020
Hanafin, J., Sunday, S., Keogan, S., & Clancy, L. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02450-w · Cited by 2
Tata Laksana Farmakologis Asma
Lukito, J. I. (2023) · Cermin Dunia Kedokteran · doi:10.55175/cdk.v50i1.335 · Cited by 2
Nurrahman, N. W. D., Putra, O. N., & Faizah, A. K. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00426 · Cited by 2
Safely Withdrawing Glucocorticoid Therapy: A Case-Based Approach
Alenazi, M., Aldahmani, K. M., & Imran, S. A. (2024) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0044-1788035 · Cited by 2
Intraoperative refractory hypotension in a patient with chronic use of low-dose prednisolone
Ito, S., Seki, H., Innami, Y., & Ouchi, T. (2020) · JA Clinical Reports · doi:10.1186/s40981-019-0307-1 · Cited by 2
Paris, A., Labrador, B., Lejeune, F., Canlet, C., Molina, J., Guinot, M., Mégret, A., Rieu, M., Thalabard, J., & Bouc, Y. L. (2021) · Metabolomics · doi:10.1007/s11306-021-01812-4 · Cited by 2
Fascia, D. T. M., Dalili, D., Rennie, W. J., Rowbotham, E. L., Carne, A., & Robinson, P. (2020) · Figshare · doi:10.6084/m9.figshare.12662642 · Cited by 2
Romanò, N., Duncan, P., McClafferty, H., Nolan, O., Ding, Q., Homer, N. Z. M., Tissier, P. L., Walker, B., Shipston, M. J., & Chambers, T. J. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.29.227330 · Cited by 2
Metadata
- Authors
- Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Aarhus University (DK)
- Corresponding author
- Dekkers, Olaf M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-06-01
- Volume
- 100
- Issue
- 6
- Pages
- 2171-2180
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022140603
- Cited by
- 456
- References
- 98
- Citations by year
- 2026: 39 · 2025: 53 · 2024: 50 · 2023: 55 · 2022: 52 · 2021: 48 · 2020: 53 · 2019: 39 · 2018: 28 · 2017: 20 · 2016: 14 · 2015: 5
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Novo Nordisk Fonden (NNF-13OC0007869)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal insufficiency, glucocorticoid-induced adrenal insufficiency, corticosteroid use, glucocorticoid dose, treatment duration, route of administration, intra-articular corticosteroids, inhaled corticosteroids, asthma, hematologic malignancies, adrenal function testing
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Insufficiency, Adult, Dosage Forms, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Administration Schedule, Humans, Inflammation, Neoplasms, Skin Diseases, Organ Transplantation, Transplantation Conditioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.